What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
| Publicado en: | Current Treatment Options in Oncology Vol. 25; no. 6; pp. 798 - 813 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178443889&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178443889 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Jun2024 vid: 25 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 178443889 177530747 10.1007/s11864-024-01218-z 178443889 ppf: 798 ppct: 15 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: What is the Optimal Treatment Strategy after Sarcoma R2 Surgery? aug: au: Chmiel, Paulina Rutkowski, Piotr Spałek, Mateusz Szumera-Ciećkiewicz, Anna Czarnecka, Anna M. affil: https://ror.org/04qcjsm24 Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781, Warsaw, Poland sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|